Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massobrio

Showing results (301-310 of 319) with videos related to

Pageof 32
Sort By:
Cancer Research|November 3, 2001
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic markerG M Yousef, L G Kyriakopoulou, A Scorilas, et al.
Journal of Pediatric Orthopedics. Part B|April 19, 2003
Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic SocietyErnesto Ippolito, Edward W Bray, Alessandro Corsi, et al.
Brain Sciences|November 24, 2022
Neuromorphic-Based Neuroprostheses for Brain Rewiring: State-of-the-Art and Perspectives in NeuroengineeringMichela Chiappalone, Vinicius R Cota, Marta Carè, et al.
Chemical Communications (Cambridge, England)|June 20, 2025
Structure, bonding and ionic mobility in Na-V-P-O glasses for energy storage applicationsSteve Dave Wansi Wendji, Rémi Piotrowski, Antonio Familiari, et al.
Cancer Research|May 3, 2006
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinomaLin Zhang, Jia Huang, Nuo Yang, et al.
Iscience|August 18, 2019
A Neuromorphic Prosthesis to Restore Communication in Neuronal NetworksStefano Buccelli, Yannick Bornat, Ilaria Colombi, et al.
Cancer Research|February 20, 2003
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosisLiu-Ying Luo, Dionyssios Katsaros, Andreas Scorilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinomaH J Arts, D Katsaros, E G de Vries, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
The Multidisciplinary Approach of Rectal Cancer: The Experience of "COMRE Group" ModelStefano Scabini, Emanuele Romairone, Davide Pertile, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 5, 2000
Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'EndometriosiF Parazzini, E Di Cintio, L Chatenoud, et al.
Pageof 32

Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Cancer Research|November 3, 2001
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic markerG M Yousef, L G Kyriakopoulou, A Scorilas, et al.
Journal of Pediatric Orthopedics. Part B|April 19, 2003
Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic SocietyErnesto Ippolito, Edward W Bray, Alessandro Corsi, et al.
Brain Sciences|November 24, 2022
Neuromorphic-Based Neuroprostheses for Brain Rewiring: State-of-the-Art and Perspectives in NeuroengineeringMichela Chiappalone, Vinicius R Cota, Marta Carè, et al.
Chemical Communications (Cambridge, England)|June 20, 2025
Structure, bonding and ionic mobility in Na-V-P-O glasses for energy storage applicationsSteve Dave Wansi Wendji, Rémi Piotrowski, Antonio Familiari, et al.
Cancer Research|May 3, 2006
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinomaLin Zhang, Jia Huang, Nuo Yang, et al.
Iscience|August 18, 2019
A Neuromorphic Prosthesis to Restore Communication in Neuronal NetworksStefano Buccelli, Yannick Bornat, Ilaria Colombi, et al.
Cancer Research|February 20, 2003
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosisLiu-Ying Luo, Dionyssios Katsaros, Andreas Scorilas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinomaH J Arts, D Katsaros, E G de Vries, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
The Multidisciplinary Approach of Rectal Cancer: The Experience of "COMRE Group" ModelStefano Scabini, Emanuele Romairone, Davide Pertile, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 5, 2000
Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'EndometriosiF Parazzini, E Di Cintio, L Chatenoud, et al.
Pageof 32